VSee Health expands board to seven, appoints Fairfax and Wickersham as Class III directors

VSEE HEALTH, INC.

Board increased from 5 to 7 members; Fairfax and Wickersham appointed as Class III directors effective July 17, 2024.
Fairfax appointed to Audit Committee and as chair of Nominating Committee; Wickersham appointed chair of Compensation Committee.
Fairfax is EVP & General Counsel of Metro (Harris County transit) and previously SVP at American Capital; both directors independent per Nasdaq.
Wickersham held a $224k secured convertible note from subsidiary iDoc, satisfied with 114k shares; no other related-party transactions.
Director compensation has not yet been determined by the Board.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

David L. Wickersham

Class III Director

VSEE · VSEE HEALTH, INC.

Effective: 2024-07-17
Filed: July 23, 2024, 7:59 PM ET

On July 17, 2024, the Board of Directors (the “Board”) of VSee Health, Inc. (the “Company”) voted to increase the size of the Board from five to seven members, and to appoint Cydonii V. Fairfax and David L. Wickersham as new Class III directors to fill the vacancies created by such increase, with such appointments effective July 17, 2024.

Appointed

Cydonii V. Fairfax

Class III Director

VSEE · VSEE HEALTH, INC.

Effective: 2024-07-17
Filed: July 23, 2024, 7:59 PM ET

On July 17, 2024, the Board of Directors (the “Board”) of VSee Health, Inc. (the “Company”) voted to increase the size of the Board from five to seven members, and to appoint Cydonii V. Fairfax and David L. Wickersham as new Class III directors to fill the vacancies created by such increase, with such appointments effective July 17, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David L. Wickersham was appointed as Class III Director at VSEE HEALTH, INC..

Action: appointed
Role: Class III Director

Exact text from the filing

On July 17, 2024, the Board of Directors (the “Board”) of VSee Health, Inc. (the “Company”) voted to increase the size of the Board from five to seven members, and to appoint Cydonii V. Fairfax and David L. Wickersham as new Class III directors to fill the vacancies created by such increase, with such appointments effective July 17, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Cydonii V. Fairfax was appointed as Class III Director at VSEE HEALTH, INC..

Action: appointed
Role: Class III Director

Exact text from the filing

On July 17, 2024, the Board of Directors (the “Board”) of VSee Health, Inc. (the “Company”) voted to increase the size of the Board from five to seven members, and to appoint Cydonii V. Fairfax and David L. Wickersham as new Class III directors to fill the vacancies created by such increase, with such appointments effective July 17, 2024.

View on SEC.gov

VSEE HEALTH, INC. filing history →

Source: SEC EDGAR

accession 0001104659-24-081912

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.